Regeneron Pharmaceuticals (REGN) slides despite FDA nod

Regeneron Pharmaceuticals Inc

shares declined 3.2% to $509.12. The FDA Panel has recommended the approval of Sanofi and Regeneron's Praluent. Share volume was 1.2 million, compared to an all-day average of 811,000